Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1/2 2Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 87INDUSTRY 58NIH 7UNKNOWN 2OTHER_GOV 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Neoplasm Metastasis 1Colorectal Neoplasms 1

Interventions

Paclitaxel 3S 1 (combination) 2Oxaliplatin 2Irinotecan 2Cisplatin 2Capecitabine 2titanium silicide 1nedaplatin 1anlotinib 1Radiation 1Pemetrexed 1Lenalidomide 1HMPL-013 1Gemcitabine 1Esophagectomy 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Carboplatin 1Bevacizumab 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × UNKNOWN × Oxaliplatin × Clear all
NCT04380103 2020-05-08

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

ChineseAMS

Phase 1/2 Unknown
106 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01542294 2016-06-14

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

ChineseAMS

Phase 1/2 Unknown
71 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡